Three years of owning McDonald's turned $10,000 into $10,043, while the same money in Cava is worth $16,762. The gap is $6,719, and Cava got there with swings of 40% or more in both directions.
Exxon Mobil raised its quarterly payout 4% to $1.03 a share, extending a 26-year run of dividends through every oil cycle since 2000. Buy after today's ex-date and you wait a full quarter for the $4.12 annual rate.
Two investors can hold the same S&P 500 covered-call ETF, collect the same monthly distributions, and walk away with very different amounts after taxes. The reason comes down to one line on the 1099 that most investors never check before buying.
Most people assume Medicare will cover the cost of aging in place or moving to a facility, and most people are wrong. Three ETFs approach the problem from completely different angles, and sizing them together changes the math on a risk that touches seven in 10 retirees.
Varsal Tech sets $5-$6 range for $16.5M NYSE American IPO
Varsal Tech's third S-1 amendment locks in a $5 to $6 range on 3 million shares, a $16.5 million raise that puts pricing within reach on NYSE American. R.F. Lafferty & Co. is running the deal, so float will be thin enough that early trading swings hard either way.
Source: SEC filing*$149 for two years (or $1.43 per week) is an introductory promotion for new members only. 62% discount based on the current list price of Stock Advisor of $199/year. Membership will renew at the then-current list price at the end of the membership term. Stock Advisor returns are 930% as compared to the S&P 500 returns of 185% as of April 7, 2026.
The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.
AI optical demand pushed Fabrinet's quarterly revenue up 45% year over year to a record, its fifth straight quarter beating expectations. Guidance for the September quarter calls for $1.375 billion to $1.425 billion in revenue and non-GAAP EPS of $4.10 to $4.25, so the acceleration is not slowing yet.
Nearly 16 points separated the best and worst names in a 110-stock board at Monday's close, with SanDisk up 8% at $1,773 and Clover Health down almost 8%. Hardware led, small-cap growth lagged.
Selling was broad, with the Dow dropping 244 points and only tech cushioning the damage. Traders are repricing September Fed odds while oil keeps climbing, so the next inflation reading now carries more weight than any earnings on the calendar.
Most Americans dread running out of money in retirement, yet millions of retirees refuse to touch the savings they have. The reason both groups are stuck comes down to a single structural problem that almost nobody talks about.
DigitalOcean is surging while the rest of cloud infrastructure slides lower, and the catalyst is a product launch built entirely on software the company did not write. Whether that distinction matters to investors depends on a question the press release does not answer.
Sponsored
Most Americans suspect they're behind on retirement and never find out. Advisor.com's free matching tool pairs you in about three minutes with a vetted fiduciary advisor who can help you with investing, taxes, retirement, estate planning, and more. No minimums. No sales call. Find out where you stand.
Pembrolizumab infusions can run into five figures per round, and Original Medicare attaches a percentage to every single one with no ceiling in sight. What happens to the patient who never knew that detail until the second bill arrived?
